{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T16:11:08Z","timestamp":1784563868973,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jaad.2021.01.067","type":"journal-article","created":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T01:52:51Z","timestamp":1611539571000},"page":"1619-1627","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["The long-term risk of lymphoma and skin cancer did not increase after topical calcineurin inhibitor use and phototherapy in a cohort of 25,694 patients with vitiligo"],"prefix":"10.1016","volume":"84","author":[{"given":"Hyun Jeong","family":"Ju","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Hee","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Hyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Won","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Heon","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Young","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong Won","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Ho","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeonghyun","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Young","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Eun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Youn","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwang Seong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Hun","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Chan Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul Jong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung","family":"Chan Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu-Hyoung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Min","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4_Suppl","key":"10.1016\/j.jaad.2021.01.067_bib1","doi-asserted-by":"crossref","first-page":"27s","DOI":"10.1177\/1203475419857668","article-title":"Off-label use of topical calcineurin inhibitors in dermatologic disorders","volume":"23","author":"Guenther","year":"2019","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2021.01.067_bib2","article-title":"FDA approves updated labeling with boxed warning and medication guide for two eczema drugs","year":"2006","journal-title":"Elidel and Protopic"},{"issue":"5","key":"10.1016\/j.jaad.2021.01.067_bib3","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1365-2133.2003.05735.x","article-title":"Topical application of the immunosuppressant tacrolimus accelerates carcinogenesis in mouse skin","volume":"149","author":"Niwa","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2021.01.067_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2407-6-7","article-title":"The carcinogenic potential of tacrolimus ointment beyond immune suppression: a hypothesis creating case report","volume":"6","author":"Becker","year":"2006","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.jaad.2021.01.067_bib5","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2133.2005.07021.x","article-title":"A population-based study of skin cancer incidence and prevalence in renal transplant recipients","volume":"154","author":"Moloney","year":"2006","journal-title":"Br J Dermatol"},{"issue":"17","key":"10.1016\/j.jaad.2021.01.067_bib6","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among US solid organ transplant recipients","volume":"306","author":"Engels","year":"2011","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.jaad.2021.01.067_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamadermatol.2020.2240","article-title":"Association between topical calcineurin inhibitor use and keratinocyte carcinoma risk among adults with atopic dermatitis","volume":"156","author":"Asgari","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2021.01.067_bib8","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/1346-8138.12099","article-title":"Guidelines for the diagnosis and treatment of vitiligo in Japan","volume":"40","author":"Oiso","year":"2013","journal-title":"J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.01.067_bib9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2133.2012.11197.x","article-title":"Guidelines for the management of vitiligo: the European Dermatology Forum consensus","volume":"168","author":"Taieb","year":"2013","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.01.067_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/phpp.12598","article-title":"Development of evidence-based consensus on critical issues in the management of patients with vitiligo: a modified Delphi study","volume":"37","author":"Bae","year":"2020","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"8","key":"10.1016\/j.jaad.2021.01.067_bib11","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1001\/jamadermatol.2019.0696","article-title":"Treatment outcomes of topical calcineurin inhibitor therapy for patients with vitiligo: a systematic review and meta-analysis","volume":"155","author":"Lee","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.01.067_bib12","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/jid.2014.527","article-title":"Maintenance therapy of adult vitiligo with 0.1% tacrolimus ointment: a randomized, double blind, placebo-controlled study","volume":"135","author":"Cavalie","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2021.01.067_bib13","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1345\/aph.1M278","article-title":"Association between exposure to topical tacrolimus or pimecrolimus and cancers","volume":"43","author":"Hui","year":"2009","journal-title":"Ann Pharmacother"},{"issue":"4","key":"10.1016\/j.jaad.2021.01.067_bib14","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/sj.jid.5700622","article-title":"Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis","volume":"127","author":"Arellano","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2021.01.067_bib15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2147\/CLEP.S146442","article-title":"A cohort study on the risk of lymphoma and skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids (Joint European Longitudinal Lymphoma and Skin Cancer Evaluation\u2013JOELLE study)","volume":"10","author":"Castellsague","year":"2018","journal-title":"Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.jaad.2021.01.067_bib16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000209289","article-title":"Topical treatments with pimecrolimus, tacrolimus and medium- to high-potency corticosteroids, and risk of lymphoma","volume":"219","author":"Schneeweiss","year":"2009","journal-title":"Dermatology"},{"issue":"3","key":"10.1016\/j.jaad.2021.01.067_bib17","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2133.2011.10363.x","article-title":"Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors","volume":"165","author":"Tennis","year":"2011","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.01.067_bib18","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jaad.2015.02.1116","article-title":"Risk of lymphoma in patients with atopic dermatitis and the role of topical treatment: a systematic review and meta-analysis","volume":"72","author":"Legendre","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.01.067_bib19","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s12185-018-2403-9","article-title":"Lymphoma epidemiology in Korea and the real clinical field including the Consortium for Improving Survival of Lymphoma (CISL) trial","volume":"107","author":"Yoo","year":"2018","journal-title":"Int J Hematol"},{"issue":"6","key":"10.1016\/j.jaad.2021.01.067_bib20","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1346-8138.2010.01046.x","article-title":"Inhibitory potency of tacrolimus ointment on skin tumor induction in a mouse model of an initiation-promotion skin tumor","volume":"38","author":"Mitamura","year":"2011","journal-title":"J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.01.067_bib21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/09546630510041088","article-title":"Non-melanoma skin cancer in patients with atopic dermatitis treated with topical tacrolimus","volume":"16","author":"Naylor","year":"2005","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"10.1016\/j.jaad.2021.01.067_bib22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000100879","article-title":"Lack of association between exposure to topical calcineurin inhibitors and skin cancer in adults","volume":"214","author":"Margolis","year":"2007","journal-title":"Dermatology"},{"issue":"5","key":"10.1016\/j.jaad.2021.01.067_bib23","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/pcmr.12781","article-title":"The 308-nm excimer laser treatment does not increase the risk of skin cancer in patients with vitiligo: a population-based retrospective cohort study","volume":"32","author":"Bae","year":"2019","journal-title":"Pigment Cell Melanoma Res"},{"issue":"5","key":"10.1016\/j.jaad.2021.01.067_bib24","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/jamadermatol.2020.0218","article-title":"Evaluation for skin cancer and precancer in patients with vitiligo treated with long-term narrowband UV-B phototherapy","volume":"156","author":"Bae","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.01.067_bib25","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1365-2133.2008.08974.x","article-title":"Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis","volume":"160","author":"Undre","year":"2009","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.01.067_bib26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2230.2009.03311.x","article-title":"Topical tacrolimus has a limited direct effect on ultraviolet B-irradiated keratinocytes: implications for its photocarcinogenic potential","volume":"35","author":"Lan","year":"2010","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.01.067_bib27","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1600-0625.2008.00812.x","article-title":"Topical pimecrolimus and tacrolimus do not accelerate photocarcinogenesis in hairless mice after UVA or simulated solar radiation","volume":"18","author":"Lerche","year":"2009","journal-title":"Exp Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.01.067_bib28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jaad.2004.08.046","article-title":"Long-term treatment of atopic dermatitis with pimecrolimus cream 1% in infants does not interfere with the development of protective antibodies after vaccination","volume":"52","author":"Papp","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.01.067_bib29","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2340\/00015555-0167","article-title":"Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic\u00a0dermatitis in children","volume":"87","author":"Remitz","year":"2007","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2021.01.067_bib30","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jaad.2020.03.075","article-title":"No evidence of increased cancer incidence in children using topical tacrolimus for atopic dermatitis","volume":"83","author":"Paller","year":"2020","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962221002243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962221002243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:59:18Z","timestamp":1759273158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962221002243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0190962221002243"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2021.01.067","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.739448404.793594872","asserted-by":"object"}]},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The long-term risk of lymphoma and skin cancer did not increase after topical calcineurin inhibitor use and phototherapy in a cohort of 25,694 patients with vitiligo","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2021.01.067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}